May 16 2016 Relmada Therapeutics Announces Promotion of Michael D. Becker to Chief Financial Officer View
May 04 2016 Relmada Therapeutics Announces Results of In Vivo Study Showing d-Methadone has Antidepressant-like Effects View
Mar 01 2016 Relmada Therapeutics Announces Publication of Full Results from Phase I Study Showing Treatment with d-Methadone to be Safe and Well Tolerated View
